Rigel Pharmaceuticals Inc (RIGL) earnings · P/E 2.7, rev $294.3M
These earnings events as JSON? API free 100/dayRigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
This RIGL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported RIGL revenue for 2025-12-31 was $294.3M. Net income was $367.0M. Revenue was up 64.1% from 2024-12-31 to 2025-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 2.7.
When the next RIGL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 64.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full RIGL research stays on the stock page; the tape stays on the quote page.
RIGL earnings FAQ
What are RIGL's latest revenue and net income?
Latest cached Rigel Pharmaceuticals Inc (RIGL) revenue for Dec 31, 2025 was $294.3M. Net income was $367.0M. Statements: https://lician.com/financials/rigl
What is RIGL's latest diluted EPS?
Latest cached Rigel Pharmaceuticals Inc (RIGL) diluted EPS for Dec 31, 2025 was $19.48.
What period does the latest RIGL earnings print cover?
The latest cached Rigel Pharmaceuticals Inc (RIGL) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did RIGL revenue change from the prior cached period?
Cached Rigel Pharmaceuticals Inc (RIGL) revenue was up 64.1% from $179.3M (Dec 31, 2024) to $294.3M (Dec 31, 2025). Statements: https://lician.com/financials/rigl
What is RIGL's P/E ratio?
Rigel Pharmaceuticals Inc (RIGL) trailing P/E is 2.72 on the latest cached fundamentals snapshot.
Where are RIGL earnings listed?
Cached earnings facts for Rigel Pharmaceuticals Inc (RIGL) are listed at https://lician.com/earnings/rigl. Statements: https://lician.com/financials/rigl
Not investment advice.